Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study

BACKGROUND: ND0612 is a continuous, subcutaneous levodopa/carbidopa delivery system in development for patients with Parkinson’s disease (PD) experiencing motor fluctuations OBJECTIVE: Evaluate the efficacy and safety of two ND0612 dosing regimens in patients with PD. METHODS: This was a 28-day open...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Parkinsons Dis
Main Authors: Olanow, C. Warren, Espay, Alberto J., Stocchi, Fabrizio, Ellenbogen, Aaron L., Leinonen, Mika, Adar, Liat, Case, Ryan J., Orenbach, Shir Fuchs, Yardeni, Tami, Oren, Sheila, Poewe, Werner
Format: Artigo
Jezik:Inglês
Izdano: IOS Press 2021
Teme:
Research Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990424/
https://ncbi.nlm.nih.gov/pubmed/33164945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-202285
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki